Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
8.65
+0.46 (5.62%)
At close: Nov 6, 2026, 4:00 PM EST
8.14
-0.51 (-5.90%)
Pre-market: Nov 9, 2026, 8:15 AM EST
Bicara Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Reiterates $7.93 → $35 | Buy | Reiterates | $7.93 → $35 | +304.62% | Nov 4, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Downgrades $8 | Sell | Downgrades | $8 | -7.51% | Oct 29, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +420.23% | Oct 29, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +293.06% | Oct 27, 2026 |
| BTIG | BTIG | Buy Maintains $39 | Buy | Maintains | $39 | +350.87% | Oct 27, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $33 | Buy | Maintains | $33 | +281.50% | Oct 26, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $30 | Buy | Maintains | $30 | +246.82% | Oct 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $39 → $41 | Buy | Maintains | $39 → $41 | +373.99% | Oct 20, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.